Addus HomeCare
Market Cap
US$1.5b
Last Updated
2021/03/05 23:20 UTC
Data Sources
Company Financials +
Executive Summary
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. More Details
Rewards
Risk Analysis
No risks detected for ADUS from our risk checks.
Snowflake Analysis
Solid track record with excellent balance sheet.
Similar Companies
Share Price & News
How has Addus HomeCare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ADUS is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: ADUS's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
-12.8%
ADUS
3.4%
US Healthcare
-0.4%
US Market
1 Year Return
22.8%
ADUS
21.7%
US Healthcare
36.3%
US Market
Return vs Industry: ADUS exceeded the US Healthcare industry which returned 21.7% over the past year.
Return vs Market: ADUS underperformed the US Market which returned 36.3% over the past year.
Shareholder returns
| ADUS | Industry | Market | |
|---|---|---|---|
| 7 Day | -12.8% | 3.4% | -0.4% |
| 30 Day | -20.9% | 0.6% | -1.3% |
| 90 Day | -10.1% | 1.0% | 4.9% |
| 1 Year | 22.8%22.8% | 23.2%21.7% | 39.2%36.3% |
| 3 Year | 132.0%132.0% | 42.0%36.2% | 48.7%39.2% |
| 5 Year | 402.0%402.0% | 80.6%67.4% | 117.0%92.8% |
Long-Term Price Volatility Vs. Market
How volatile is Addus HomeCare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 days ago | Simply Wall St
Addus HomeCare Corporation's (NASDAQ:ADUS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?2 weeks ago | Simply Wall St
Read This Before Buying Addus HomeCare Corporation (NASDAQ:ADUS) Shares1 month ago | Simply Wall St
Is Addus HomeCare Corporation (NASDAQ:ADUS) Expensive For A Reason? A Look At Its Intrinsic ValueValuation
Is Addus HomeCare undervalued compared to its fair value and its price relative to the market?
44.17x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ADUS ($93.83) is trading above our estimate of fair value ($74.58)
Significantly Below Fair Value: ADUS is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ADUS is poor value based on its PE Ratio (44.2x) compared to the US Healthcare industry average (23.3x).
PE vs Market: ADUS is poor value based on its PE Ratio (44.2x) compared to the US market (21.5x).
Price to Earnings Growth Ratio
PEG Ratio: ADUS is poor value based on its PEG Ratio (2.3x)
Price to Book Ratio
PB vs Industry: ADUS is good value based on its PB Ratio (2.8x) compared to the US Healthcare industry average (3.3x).
Next Steps
Future Growth
How is Addus HomeCare forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
19.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ADUS's forecast earnings growth (19.6% per year) is above the savings rate (2%).
Earnings vs Market: ADUS's earnings (19.6% per year) are forecast to grow faster than the US market (19.3% per year).
High Growth Earnings: ADUS's earnings are forecast to grow, but not significantly.
Revenue vs Market: ADUS's revenue (9.8% per year) is forecast to grow slower than the US market (10% per year).
High Growth Revenue: ADUS's revenue (9.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ADUS's Return on Equity is forecast to be low in 3 years time (11.2%).
Next Steps
Past Performance
How has Addus HomeCare performed over the past 5 years?
25.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ADUS has high quality earnings.
Growing Profit Margin: ADUS's current net profit margins (4.3%) are higher than last year (4%).
Past Earnings Growth Analysis
Earnings Trend: ADUS's earnings have grown significantly by 25.8% per year over the past 5 years.
Accelerating Growth: ADUS's earnings growth over the past year (28.1%) exceeds its 5-year average (25.8% per year).
Earnings vs Industry: ADUS earnings growth over the past year (28.1%) exceeded the Healthcare industry 16.5%.
Return on Equity
High ROE: ADUS's Return on Equity (6.4%) is considered low.
Next Steps
Financial Health
How is Addus HomeCare's financial position?
Financial Position Analysis
Short Term Liabilities: ADUS's short term assets ($287.7M) exceed its short term liabilities ($143.9M).
Long Term Liabilities: ADUS's short term assets ($287.7M) exceed its long term liabilities ($230.0M).
Debt to Equity History and Analysis
Debt Level: ADUS's debt to equity ratio (37.6%) is considered satisfactory.
Reducing Debt: ADUS's debt to equity ratio has increased from 0.5% to 37.6% over the past 5 years.
Debt Coverage: ADUS's debt is well covered by operating cash flow (56.1%).
Interest Coverage: ADUS's interest payments on its debt are well covered by EBIT (19.9x coverage).
Balance Sheet
Next Steps
Dividend
What is Addus HomeCare current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ADUS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ADUS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ADUS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ADUS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ADUS's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.2yrs
Average management tenure
CEO
R. Allison (64 yo)
5.17yrs
Tenure
US$1,992,513
Compensation
Mr. R. Dirk Allison has been the Chief Executive Officer and President of Addus HealthCare Inc. since January 16, 2016. Mr. Allison has been the Chief Executive Officer and President at Addus HomeCare Corp...
CEO Compensation Analysis
Compensation vs Market: R.'s total compensation ($USD1.99M) is below average for companies of similar size in the US market ($USD3.67M).
Compensation vs Earnings: R.'s compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.17yrs | US$1.99m | 0.42% $ 6.1m | |
| CFO, Executive VP | 4.83yrs | US$930.80k | 0.22% $ 3.2m | |
| Executive VP & Chief Legal Officer | 1.92yrs | US$1.87m | 0.074% $ 1.1m | |
| Executive VP & Chief Development Officer | 3.17yrs | US$1.48m | 0.056% $ 814.0k | |
| Executive VP & Chief Information Officer | 1.67yrs | US$1.47m | 0.040% $ 586.9k | |
| COO & Executive VP | 4.17yrs | US$1.67m | 0.26% $ 3.8m | |
| Senior VP & Chief Compliance Officer | 2.83yrs | no data | no data | |
| Executive VP & Chief Human Resource Officer | 3.58yrs | US$952.83k | 0.099% $ 1.4m | |
| Executive VP & Chief Strategy Officer | 13.42yrs | US$911.99k | 0.20% $ 3.0m | |
| Senior Vice President of National Contracts & Business Development | 2.83yrs | no data | no data | |
| Senior Vice President of Project Management & Integration | 3.17yrs | no data | no data | |
| Senior Vice President of Operations | 3.17yrs | no data | no data |
3.2yrs
Average Tenure
55yo
Average Age
Experienced Management: ADUS's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.17yrs | US$1.99m | 0.42% $ 6.1m | |
| Independent Director | 14.5yrs | US$138.77k | 0.14% $ 2.0m | |
| Independent Chairman | 5.17yrs | US$174.52k | 0.14% $ 2.0m | |
| Independent Director | 7yrs | US$162.27k | 0.069% $ 1.0m | |
| Independent Director | 4.42yrs | US$149.77k | 0.042% $ 614.8k | |
| Independent Director | 4.42yrs | US$128.77k | 0.039% $ 568.3k | |
| Director | 0.17yr | no data | 0.0029% $ 42.3k | |
| Director | 0.17yr | no data | 0.0029% $ 42.3k | |
| Independent Director | 2.42yrs | US$139.77k | 0.019% $ 282.5k |
4.4yrs
Average Tenure
63yo
Average Age
Experienced Board: ADUS's board of directors are considered experienced (4.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Addus HomeCare Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Addus HomeCare Corporation
- Ticker: ADUS
- Exchange: NasdaqGS
- Founded: 1979
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$1.458b
- Shares outstanding: 15.67m
- Website: https://www.addus.com
Number of Employees
Location
- Addus HomeCare Corporation
- 6303 Cowboys Way
- Suite 600
- Frisco
- Texas
- 75034
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ADUS | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Oct 2009 |
| A41 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Oct 2009 |
Biography
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/03/05 23:20 |
| End of Day Share Price | 2021/03/05 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.